American Society of Clinical Oncology (ASCO) Annual Meeting

Scheduled For: Friday, June 3rd, 2016 View all Events

Date: June 3 – 7, 2016
 
Booth #: 13090
 
Website: ASCO Annual Meeting
 
Location: McCormick Place | 3 Chicago, IL

Leaders On-site:

 

Panna Sharma
CEO & President 
 
Greg Ash
VP, Clinical Market Development 
 
Omar Ceballos
Director of Clinical Sales, Eastern Region 
 
Weiyi Chen, Ph.D., HCLC (ABB)
Director, Molecular Diagnostics 
 
Kamala Maddali, DVM, Ph.D.
VP, Biopharma Collaborations & Companion Diagnostics 
 
Narasimha Marella, Ph.D.
VP of Operations 
 
Rita Shaknovich, MD, Ph.D.
Group Medical Director, & VP of Hematopathology

Ask Us About Our Latest Innovations: Comprehensive Immuno-Oncology Testing Portfolio For Use In Clinical Trials, Translational Research, and Therapy Selection For Patients

Focus::LymphomaTM NGS Panel for B-cell Lymphomas
CGI’s Focus::LymphomaTM Next Generation Sequencing panel is now available for routine clinical management and therapy selection for lymphoma patients, giving hope to patients who at times have failed first line treatments.

Focus::OncomineTM NGS Panel For Solid Tumors
CGI’s Focus::OncomineTM NGS panel is CLIA validated and available for both clinical care and for clinical trials being performed by biotech and pharmaceutical companies.

FDA-Approved PD-L1 Testing Now Available
The FDA approved PD-L1 (IHC) 22C3 pharmDx companion diagnostic test for KEYTRUDA® (pembrolizumab) is now available at CGI to assess PD-L1 expression in Non-Small Cell Lung Cancer.

[formidable id=12 title=true description=true]